Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research note issued to investors on Friday. The brokerage issued a sell rating on the medical equipment provider’s stock.

Aethlon Medical Stock Performance

Shares of NASDAQ AEMD remained flat at $0.40 during trading on Friday. The stock had a trading volume of 83,274 shares, compared to its average volume of 1,874,397. The stock has a 50 day simple moving average of $0.40 and a 200 day simple moving average of $0.52. Aethlon Medical has a 1-year low of $0.24 and a 1-year high of $2.35. The firm has a market capitalization of $5.62 million, a PE ratio of -0.10 and a beta of 1.74.

Aethlon Medical (NASDAQ:AEMD) last posted its quarterly earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.44) by $0.10. During the same quarter in the prior year, the company earned ($1.30) earnings per share. On average, sell-side analysts expect that Aethlon Medical will post -1.1 earnings per share for the current year.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.